2015 中国慢性乙型肝炎防治指南解读

2016-03-10 中华医学会肝病学分会 《中国医学前沿杂志(电子版)》2016 年第 8 卷第 3 期

中华医学会感染病学分会和肝病学分会于2005年组织国内专家制定了《慢性乙型肝炎防治指南》(第 1 版),并于2010年第1次修订。自2010年以来,国内外有关慢性乙型肝炎的基础和临床研究取得很大进展,因此,中华医学会感染病学分会和肝病学分会再次组织专家对《慢性乙型肝炎防治指南》进行修订,并于2015年发布(以下简称 2015 版指南)。本文就2015年版指南更新要点进行介绍和解读。

中文标题:

2015 中国慢性乙型肝炎防治指南解读

发布日期:

2016-03-10

简要介绍:

中华医学会感染病学分会和肝病学分会于2005年组织国内专家制定了《慢性乙型肝炎防治指南》(第 1 版),并于2010年第1次修订。自2010年以来,国内外有关慢性乙型肝炎的基础和临床研究取得很大进展,因此,中华医学会感染病学分会和肝病学分会再次组织专家对《慢性乙型肝炎防治指南》进行修订,并于2015年发布(以下简称 2015 版指南)。本文就2015年版指南更新要点进行介绍和解读。


制定者:
中华医学会感染病学分会和肝病学分会

拓展指南:慢性乙型肝炎相关指南:

下载附件:

(因为版权问题,不支持下载)

评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=106645, encodeId=995b10664507, content=新理念,值得重视!值得学习。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160601/IMG574E13FEE55F33222.jpg, createdBy=929c1478678, createdName=zibozhouping, createdTime=Mon Aug 29 07:58:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=105217, encodeId=1c3410521e05, content=实用,特别实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fcad1943078, createdName=1e0f7307m29(暂无匿称), createdTime=Sat Aug 27 00:25:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94996, encodeId=bb5f94996e3, content=肝炎病毒耐药性也要得到相当的重视, beContent=null, objectType=guider, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b09f1636586, createdName=onetree, createdTime=Fri Jul 29 00:00:00 CST 2016, time=2016-07-29, status=1, ipAttribution=)]
    2016-08-29 zibozhouping

    新理念,值得重视!值得学习。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=106645, encodeId=995b10664507, content=新理念,值得重视!值得学习。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160601/IMG574E13FEE55F33222.jpg, createdBy=929c1478678, createdName=zibozhouping, createdTime=Mon Aug 29 07:58:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=105217, encodeId=1c3410521e05, content=实用,特别实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fcad1943078, createdName=1e0f7307m29(暂无匿称), createdTime=Sat Aug 27 00:25:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94996, encodeId=bb5f94996e3, content=肝炎病毒耐药性也要得到相当的重视, beContent=null, objectType=guider, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b09f1636586, createdName=onetree, createdTime=Fri Jul 29 00:00:00 CST 2016, time=2016-07-29, status=1, ipAttribution=)]
    2016-08-27 1e0f7307m29(暂无匿称)

    实用,特别实用

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=106645, encodeId=995b10664507, content=新理念,值得重视!值得学习。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160601/IMG574E13FEE55F33222.jpg, createdBy=929c1478678, createdName=zibozhouping, createdTime=Mon Aug 29 07:58:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=105217, encodeId=1c3410521e05, content=实用,特别实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fcad1943078, createdName=1e0f7307m29(暂无匿称), createdTime=Sat Aug 27 00:25:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94996, encodeId=bb5f94996e3, content=肝炎病毒耐药性也要得到相当的重视, beContent=null, objectType=guider, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b09f1636586, createdName=onetree, createdTime=Fri Jul 29 00:00:00 CST 2016, time=2016-07-29, status=1, ipAttribution=)]
    2016-07-29 onetree

    肝炎病毒耐药性也要得到相当的重视

    0